<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font23 { font-size : 23; } .font25 { font-size : 25; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">virus </span>
   <span class="font25">antiviral </span>
   <span class="font23">[]. </span>
   <span class="font21">Res./j.antiviral... </span>
   <span class="font19">treatment </span>
   <span class="font19">viruses </span>
   <span class="font18">infections </span>
   <span class="font18">viral </span>
   <span class="font17">antivirals </span>
   <span class="font17">compounds </span>
   <span class="font17">[], </span>
   <span class="font17">vitro </span>
   <span class="font16">fever </span>
   <span class="font16">activity </span>
   <span class="font16">drug </span>
   <span class="font15">clinical </span>
   <span class="font15">infection </span>
   <span class="font15">hemorrhagic </span>
   <span class="font15">influenza </span>
   <span class="font15">inhibitor </span>
   <span class="font15">biological </span>
   <span class="font15">agents </span>
   <span class="font14">potential </span>
   <span class="font14">broad-spectrum </span>
   <span class="font14">human </span>
   <span class="font14">{border-style </span>
   <span class="font14">Ebola </span>
   <span class="font14">use </span>
   <span class="font13">effective </span>
   <span class="font13">models </span>
   <span class="font13">px;} </span>
   <span class="font13">ribavirin </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">FDA </span>
   <span class="font13">animal </span>
   <span class="font13">research </span>
   <span class="font13">approved </span>
   <span class="font13">efficacy </span>
   <span class="font13">favipiravir </span>
   <span class="font13">number </span>
   <span class="font13">RNA </span>
   <span class="font13">encephalitis </span>
   <span class="font13">threat </span>
   <span class="font13">case </span>
   <span class="font13">developed </span>
   <span class="font13">drugs </span>
   <span class="font13">inhibits </span>
   <span class="font13">severe </span>
   <span class="font12">cause </span>
   <span class="font12">causing </span>
   <span class="font12">Zika </span>
   <span class="font12">cell </span>
   <span class="font12">development </span>
   <span class="font12">measles </span>
   <span class="font12">model </span>
   <span class="font12">used </span>
   <span class="font12">Chikungunya </span>
   <span class="font12">high </span>
   <span class="font12">including </span>
   <span class="font12">polymerase </span>
   <span class="font12">shown </span>
   <span class="font12">caused </span>
   <span class="font12">drugs. </span>
   <span class="font12">flaviviruses </span>
   <span class="font12">health </span>
   <span class="font12">novel </span>
   <span class="font12">replication </span>
   <span class="font12">testing </span>
   <span class="font12">treat </span>
   <span class="font12">yellow </span>
   <span class="font11">available </span>
   <span class="font11">cells </span>
   <span class="font11">currently </span>
   <span class="font11">design </span>
   <span class="font11">early </span>
   <span class="font11">infected </span>
   <span class="font11">inhibit </span>
   <span class="font11">mouse </span>
   <span class="font11">resistance </span>
   <span class="font11">respiratory </span>
   <span class="font11">target </span>
   <span class="font11">virusAntivir </span>
   <span class="font11">CHIKV </span>
   <span class="font11">Lassa </span>
   <span class="font11">active </span>
   <span class="font11">candidates </span>
   <span class="font11">cellular </span>
   <span class="font11">chikungunya </span>
   <span class="font11">compound </span>
   <span class="font11">disease </span>
   <span class="font11">effects </span>
   <span class="font11">entry </span>
   <span class="font11">enveloped </span>
   <span class="font11">evaluation </span>
   <span class="font11">fatality </span>
   <span class="font11">fevers </span>
   <span class="font11">inhibitors </span>
   <span class="font11">public </span>
   <span class="font11">px; </span>
   <span class="font11">requires </span>
   <span class="font11">shows </span>
   <span class="font11">small </span>
   <span class="font11">{font-family </span>
   <span class="font11">agents. </span>
   <span class="font11">candidate </span>
   <span class="font11">containment. </span>
   <span class="font11">described </span>
   <span class="font11">font-size </span>
   <span class="font11">lethal </span>
   <span class="font11">medical </span>
   <span class="font11">natural </span>
   <span class="font11">nucleoside </span>
   <span class="font11">potent </span>
   <span class="font11">significant </span>
   <span class="font11">small-molecule </span>
   <span class="font11">targeting </span>
   <span class="font11">targets </span>
   <span class="font11">using </span>
   <span class="font11">vaccine </span>
   <span class="font11">viruses, </span>
   <span class="font11">Africa </span>
   <span class="font11">Crimean-Congo </span>
   <span class="font11">FDA-approved </span>
   <span class="font11">Ribavirin </span>
   <span class="font11">Venezuelan </span>
   <span class="font11">agent </span>
   <span class="font11">agents, </span>
   <span class="font11">alphaviruses </span>
   <span class="font11">approach </span>
   <span class="font11">biodefense </span>
   <span class="font11">biothreat </span>
   <span class="font11">considered </span>
   <span class="font11">countermeasures </span>
   <span class="font11">dengue </span>
   <span class="font11">different </span>
   <span class="font11">double; </span>
   <span class="font11">equine </span>
   <span class="font11">family </span>
   <span class="font11">fatal </span>
   <span class="font11">fever, </span>
   <span class="font11">hepatitis </span>
   <span class="font11">lead </span>
   <span class="font11">licensed </span>
   <span class="font11">list </span>
   <span class="font11">mainly </span>
   <span class="font11">mechanism </span>
   <span class="font11">members </span>
   <span class="font11">mice </span>
   <span class="font11">mortality </span>
   <span class="font11">non-human </span>
   <span class="font11">outbreak </span>
   <span class="font11">outbreaks </span>
   <span class="font11">poxvirus </span>
   <span class="font11">primates </span>
   <span class="font11">recent </span>
   <span class="font11">recently </span>
   <span class="font11">review </span>
   <span class="font11">risk </span>
   <span class="font11">role </span>
   <span class="font11">silico </span>
   <span class="font11">smallpox </span>
   <span class="font11">sofosbuvir </span>
   <span class="font11">syndrome </span>
   <span class="font11">toxicity </span>
   <span class="font11">virus-specific </span>
   <span class="font11">virusesAntivir </span>
   <span class="font11">vivo </span>
   <span class="font11">(Step </span>
   <span class="font11">(T-) </span>
   <span class="font11">(Table√Ç </span>
   <span class="font11">(e.g., </span>
   <span class="font11">AMed </span>
   <span class="font11">Agents </span>
   <span class="font11">Antiviral </span>
   <span class="font11">Dengue </span>
   <span class="font11">Group </span>
   <span class="font11">However, </span>
   <span class="font11">Infect </span>
   <span class="font11">Res./S-()- </span>
   <span class="font11">West </span>
   <span class="font11">approval </span>
   <span class="font11">barrier </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">brincidofovir </span>
   <span class="font11">cases </span>
   <span class="font11">conditions </span>
   <span class="font11">development. </span>
   <span class="font11">does </span>
   <span class="font11">endemic </span>
   <span class="font11">experimental </span>
   <span class="font11">filovirus </span>
   <span class="font11">filoviruses </span>
   <span class="font11">flavivirus </span>
   <span class="font11">focus </span>
   <span class="font11">include </span>
   <span class="font11">interesting </span>
   <span class="font11">large </span>
   <span class="font11">new </span>
   <span class="font11">numbers </span>
   <span class="font11">outcomes </span>
   <span class="font11">paramyxoviruses </span>
   <span class="font11">patients </span>
   <span class="font11">promising </span>
   <span class="font11">pulmonary </span>
   <span class="font11">rates </span>
   <span class="font11">reported </span>
   <span class="font11">solid; </span>
   <span class="font11">ss-RNA </span>
   <span class="font11">tested </span>
   <span class="font11">therapeutic </span>
   <span class="font11">therapy </span>
   <span class="font11">transmission </span>
   <span class="font11">transmitted </span>
   <span class="font11">type </span>
   <span class="font11">vaccines </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">BSL- </span>
   <span class="font10">CCHFV </span>
   <span class="font10">Chem </span>
   <span class="font10">Clin </span>
   <span class="font10">FGI- </span>
   <span class="font10">Handling </span>
   <span class="font10">Human </span>
   <span class="font10">MBDC </span>
   <span class="font10">Nipah </span>
   <span class="font10">OPV </span>
   <span class="font10">VEEV </span>
   <span class="font10">Valley </span>
   <span class="font10">]), </span>
   <span class="font10">action </span>
   <span class="font10">acute </span>
   <span class="font10">adenosine </span>
   <span class="font10">analogue </span>
   <span class="font10">bold </span>
   <span class="font10">brain </span>
   <span class="font10">bunyaviruses </span>
   <span class="font10">canine </span>
   <span class="font10">central </span>
   <span class="font10">combination </span>
   <span class="font10">compared </span>
   <span class="font10">compassionate </span>
   <span class="font10">complex </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">deliberate </span>
   <span class="font10">diseases </span>
   <span class="font10">distemper </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">evaluated </span>
   <span class="font10">examples </span>
   <span class="font10">filo-, </span>
   <span class="font10">genome </span>
   <span class="font10">global </span>
   <span class="font10">hantavirus </span>
   <span class="font10">host </span>
   <span class="font10">hosts </span>
   <span class="font10">infections, </span>
   <span class="font10">inhibiting </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">known </span>
   <span class="font10">models. </span>
   <span class="font10">molecule </span>
   <span class="font10">need </span>
   <span class="font10">options </span>
   <span class="font10">order </span>
   <span class="font10">overview </span>
   <span class="font10">pathogenic </span>
   <span class="font10">phase </span>
   <span class="font10">point </span>
   <span class="font10">potentially </span>
   <span class="font10">protease </span>
   <span class="font10">protein </span>
   <span class="font10">pt;} </span>
   <span class="font10">rapid </span>
   <span class="font10">rate </span>
   <span class="font10">reduces </span>
   <span class="font10">reduction </span>
   <span class="font10">regulatory </span>
   <span class="font10">relevance </span>
   <span class="font10">remdesivir </span>
   <span class="font10">rodent </span>
   <span class="font10">secondary </span>
   <span class="font10">select </span>
   <span class="font10">session </span>
   <span class="font10">similar </span>
   <span class="font10">specific </span>
   <span class="font10">strains </span>
   <span class="font10">studies </span>
   <span class="font10">susceptibility </span>
   <span class="font10">treatments </span>
   <span class="font10">trial </span>
   <span class="font10">vaccinia </span>
   <span class="font10">virus, </span>
   <span class="font10">zoonotic </span>
  </p>
 </body>
</html>
